- Hepatitis C Viral Kinetics as a Determinant of Stopping Pegylated Interferon and Ribavirin in Genotype 1 Infection
-
Kim DY
- KMID: 1792354
- Gut Liver.
- 2014 Jul;8(4):335-336.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Combination of Pegylated Interferon and Nucleos(t)ide Therapy: Toward a Cure of Hepatitis B Virus Infection?
-
Cho EJ, Lee JH, Yoon JH
- KMID: 2412034
- Gut Liver.
- 2016 Jul;10(4):497-498.
- doi: 10.5009/gnl15307
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Chronic Hepatitis C: Shorter Treatment Duration for Genotype 2 or 3 Infection
-
Jeong SH
- KMID: 760731
- Korean J Hepatol.
- 2007 Sep;13(3):301-303.
- doi: 10.3350/kjhep.2007.13.3.301
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Peginterferon-alpha and Ribavirin Combination Therapy in Chronic Hepatitis C
-
Han KH, Yoon YH
- KMID: 760535
- Korean J Hepatol.
- 2004 Jun;10(2):81-87.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of chronic hepatitis C: Efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients
-
Lee YJ
- KMID: 1073296
- Korean J Hepatol.
- 2008 Dec;14(4):443-445.
- doi: 10.3350/kjhep.2008.14.4.443
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Suppression of Viral Replication in Chronic Hepatitis B: Outcomes and Future Directions
-
Shim JJ
- KMID: 2155637
- Gut Liver.
- 2015 May;9(3):265-266.
- doi: 10.5009/gnl15105
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment with pegylated interferon and ribavirin in a patient with fibrosing cholestatic hepatitis due to recurrent hepatitis C after liver transplantation
-
Kim BK, Kwon SY, Ko SY, Choe WH, Lee CH, Han HS, Chang SH
- KMID: 1073304
- Korean J Hepatol.
- 2008 Dec;14(4):519-524.
- doi: 10.3350/kjhep.2008.14.4.519
Fibrosing cholestatic hepatitis (FCH) is the most devastating manifestation of recurrent hepatitis C in transplant recipients with hepatitis C virus (HCV), possibly leading to death or retransplantation. Although FCH was... -
- CITED
-
- Close
- SHARE
-
- Close
- Oromucosal Cytokine Therapy: Mechanism(s) of Action
-
Tovey MG
- KMID: 1123161
- Korean J Hepatol.
- 2002 Jun;8(2):125-131.
Oromucosal cytokine therapy allows large amounts of cytokines to be administered with improved outcome and without dose limiting toxicity. Orally administered cytokines exert their effects by a novel two pronged... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C
-
Jung CH, Um SH, Kim TH, Yim SY, Suh SJ, Yim HJ, Seo YS, Choi HS, Chun HJ
- KMID: 2412080
- Gut Liver.
- 2016 Sep;10(5):808-817.
- doi: 10.5009/gnl15360
BACKGROUND/AIMS: Peginterferon plus ribavirin remains a standard therapy for patients with chronic hepatitis C (CHC) in Korea. We investigated the efficacy and long-term outcome of peginterferon and ribavirin therapy in... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Efficacy of Clevudine, Entecavir and Lamivudine in Treatment-naive Patients with HBeAg-Positive Chronic Hepatitis B
-
Bae SH, Baek YH, Lee SW, Han SY
- KMID: 1775852
- Korean J Gastroenterol.
- 2010 Dec;56(6):365-372.
- doi: 10.4166/kjg.2010.56.6.365
BACKGROUND/AIMS: Clevudine is a potent antiviral agent that has demonstrated efficacy in patients with chronic hepatitis B. This study compared the efficacy of clevudine (C), entecavir (E) and lamivudine (L)... -
- CITED
-
- Close
- SHARE
-
- Close
- Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C Virus
-
Tamai H, Ida Y, Kawashima , Shingaki N, Shimizu R, Moribata K, Nasu T, Maekita T, Iguchi M, Kato J, Nakao T, Kitano M
- KMID: 2412236
- Gut Liver.
- 2017 Jul;11(4):551-558.
- doi: 10.5009/gnl16525
BACKGROUND/AIMS: The present study aimed to evaluate the safety and efficacy of simeprevir-based triple therapy with reduced doses of pegylated interferon (PEG-IFN) and ribavirin for interferon (IFN) ineligible patients, such... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Effect of Adefovir Dipivoxil on Recurrent or de novo Infection of Hepatitis B Virus after Liver Transplantation: A Preliminary Report
-
Kim KK, Kim KH, Hwang S, Ahn CS, Moon DB, Ha TY, Lee SG
- KMID: 1767493
- Korean J Gastroenterol.
- 2005 Mar;45(3):174-180.
BACKGROUND/AIMS: Anti-viral therapy using hepatitis B immune globulin and lamivudine could not prevent HBV recurrence after liver transplantation (LT) completely. Adefovir dipivoxil is a acyclic nucleotide phosphate analogue and known... -
- CITED
-
- Close
- SHARE
-
- Close
- Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus
-
Tamai H, Shingaki N, Mori Y, Moribata K, Kawashima , Maeda Y, Niwa T, Deguchi H, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M
- KMID: 2412052
- Gut Liver.
- 2016 Jul;10(4):617-623.
- doi: 10.5009/gnl15193
BACKGROUND/AIMS: This study aimed to predict sustained viral response (SVR) to low-dose pegylated interferon (PEG-IFN) plus ribavirin of elderly and/or cirrhotic patients with genotype 2 hepatitis C virus (HCV) using... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes after Discontinuation of Lamivudine in Chronic Hepatitis B Patients with Lamivudine Resistant HBV Mutant
-
Kim JK, Hwang SG, Park H, Choi HY, Cho HJ, Ko KH, Hong SP, Park PW, Kim NK, Rim KS
- KMID: 760605
- Korean J Hepatol.
- 2005 Sep;11(3):227-242.
BACKGROUND/AIMS: The therapeutic strategies of applying adefovir for treating lamivudine resistant HBV mutants are controversial. Thus, we observed the clinical outcomes after discontinuation of lamivudine to establish the timing... -
- CITED
-
- Close
- SHARE
-
- Close
- Prediction of a Null Response to Pegylated Interferon alpha-2b Plus Ribavirin in Patients with High Viral Load Genotype 1b Hepatitis C
-
Wada Y, Tamai H, Kawashima , Shingaki N, Mori Y, Kawaguchi , Moribata K, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M
- KMID: 1792366
- Gut Liver.
- 2014 Jul;8(4):421-427.
BACKGROUND/AIMS: The present study aimed to clarify whether virological response within 2 weeks after therapy initiation can predict a null response to pegylated interferon alpha-2b plus ribavirin therapy in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C
-
Lee HJ, Eun JR, Choi JW, Kim KO, Moon HJ
- KMID: 1073329
- Korean J Hepatol.
- 2008 Mar;14(1):46-57.
- doi: 10.3350/kjhep.2008.14.1.46
BACKGROUND/AIMS: This study compared the efficacy and safety of combined peginterferon alfa (PEG-IFN) and ribavirin with that of combined interferon alpha (IFN-alpha) and ribavirin, according to the treatment duration... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B
-
Lee S, Park JY, Song K, Kim DY, Kim BK, Kim SU, Ku HJ, Han KH, Ahn SH
- KMID: 2377936
- Gut Liver.
- 2015 Nov;9(6):776-783.
- doi: 10.5009/gnl14297
BACKGROUND/AIMS: The aim of this study was to evaluate the estimated glomerular filtration rate (eGFR) during telbivudine (LdT) versus entecavir (ETV) treatment in chronic hepatitis B (CHB) patients with underlying... -
- CITED
-
- Close
- SHARE
-
- Close
- 24 Weeks Treatment with Pegylated Interferon Alfa Plus Ribavirin May Be Possible in Genotype 1 Chronic Hepatitis C Patients with Rapid Virological Response Who Have Low Pretreatment Viremia
-
Moon SS, Kang HG, Seo JA, Jung EU, Lee SH, Park SJ, Lee YJ, Seol SY
- KMID: 1775876
- Korean J Gastroenterol.
- 2010 Jul;56(1):33-38.
- doi: 10.4166/kjg.2010.56.1.33
BACKGROUND/AIMS: The standard treatment for chronic hepatitis C infected with hepatitis C virus (HCV) genotype 1 is a combination of pegylated interferon alfa and ribavirin over a 48 weeks period.... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection
-
Kang MJ, Jung EU, Park SW, Choi P, Kim JH, Park SJ, Park ET, Lee YJ, Lee SH, Seol SY
- KMID: 1381462
- Korean J Hepatol.
- 2008 Sep;14(3):318-330.
- doi: 10.3350/kjhep.2008.14.3.318
BACKGROUND/AIMS: We assessed the efficacy and safety of pegylated interferon (peginterferon) plus ribavirin and identified the predictors of a sustained virologic response (SVR) in Korean patients with chronic hepatitis... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation
-
Lee SS, Ahn JS, Jung SH, Ahn SY, Kim JY, Jang HC, Kang SJ, Jang MO, Yang DH, Kim YK, Lee JJ, Kim HJ
- KMID: 2160686
- Korean J Intern Med.
- 2015 Mar;30(2):212-218.
- doi: 10.3904/kjim.2015.30.2.212
BACKGROUND/AIMS: BK virus (BKV) has been associated with late-onset hemorrhagic cystitis (HC) in recipients of hematopoietic stem cell transplantation (HSCT). Cidofovir has been used at higher doses (3 to 5... -
- CITED
-
- Close
- SHARE
-
- Close
